近日,美国感染病学会(IDSA)发布了《IDSA 2024抗微生物耐药革兰阴性菌治疗指引》(IDSA 2024 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections),为临床医生提供了宝贵的治疗参考。该文件主要针对产超广谱β-内酰胺酶肠杆目细菌(ESB...
近日,美国感染病学会(IDSA)发布了《IDSA 2024抗微生物耐药革兰阴性菌治疗指引》(IDSA 2024 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections),为临床医生提供了宝贵的治疗参考。该文件主要针对产超广谱β-内酰胺酶肠杆目细菌(ESBL-E)、产AmpC β-内酰胺酶肠杆目细菌(AmpC-E)、碳青...
近期,美国感染病学会(IDSA)更新发布了2023版的《抗微生物耐药革兰阴性细菌感染的治疗指引》(IDSA 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections),现整理相关建议内容如下。该“指南”实为指引文件,则与国内实践有所差异;且本文编译可能有所误差或纰漏,请以原文为准参考。 登录以...
临床用药评价公众号评:虽然2023年IDSA GUIDELINES《Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections》很具有临床借鉴意义,但国内仍需要谨慎引荐,毕竟这份指南的很多数据基于...
近期,美国感染病学会(IDSA)更新发布了2023版的《抗微生物耐药革兰阴性细菌感染的治疗指引》(IDSA 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections),现整理相关建议内容如下。该“指南”实为指引文件,则与国内实践有所差异;且本文编译可能有所误差或纰漏,请以原文为准参考。
参考资料:Tamma PD, Aitken SL,et al.Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clin Infect Dis. 2023 Jul 18:ciad428. doi: 10.1093/cid/ciad428. >>>直接点击阅读:2023 IDSA指南:抗菌药物耐药革兰氏阴性菌感染的治疗...
参考资料:Tamma PD, Aitken SL,et al.Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections. Clin Infect Dis. 2023 Jul 18:ciad428. doi: 10.1093/cid/ciad428.
Tamma PD, Aitken SL, Bonomo RA,et al.Infectious Diseases Society of America Antimicrobial Resistant Treatment Guidance: Gram-Negative Bacterial Infections. Clin Infect Dis. 2020 Oct 27. pii: ciaa1478. doi: 10.1093/cid/ciaa1478. (有效期至2021.10.30,辉瑞医学信息部)...
参考来源:Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America Antimicrobial-Resistant Treatment Guidance: Gram-Negative Bacterial Infections. Infectious Diseases Society of America 2022; Version 1.1.©...
内容提示: Infectious Diseases Society of America Antimicrobial Resistant Treatment Guidance: Gram-Negative Bacterial Infections A Focus on Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance...